tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graham Parry, 3 are a HOLD (42.86%), 1 are a SELL (14.29%), 3 are a BUY (42.86%).
Analyst Graham Parry, currently employed at BAML, carries an average stock price target met ratio of 25% that have a potential upside of 18.37% achieved within 253 days.
Graham Parry’s has documented 12 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 12-Sep-2023.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 3/28/2023. The price target of $113.35 was fulfilled within 505 days with a profit of $30.45 (36.73%) receiving and performance score of 0.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$41
$3.7 (9.92%)
3 months 3 days ago
(02-Dec-2024)
0/1 (0%)
$6.69 (19.50%)
Hold
$53
3 months 21 days ago
(12-Nov-2024)
2/4 (50%)
$15.58 (41.64%)
379
Buy
7 months 4 days ago
(01-Aug-2024)
1/13 (7.69%)
$-10.5 (-32.65%)
64
Buy
$45
$7.7 (20.64%)
$47
7 months 17 days ago
(16-Jul-2024)
1/3 (33.33%)
$6.9 (18.11%)
2259
Buy
$19.52
1 years 20 days ago
(13-Feb-2024)
0/3 (0%)
$-13.88 (-41.56%)
What Year was the first public recommendation made by Graham Parry?
